These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 36299884)
1. Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential. Nakamura M; Satoh N; Horita S; Nangaku M Front Pharmacol; 2022; 13():1015204. PubMed ID: 36299884 [TBL] [Abstract][Full Text] [Related]
2. Insulin promotes sodium transport but suppresses gluconeogenesis via distinct cellular pathways in human and rat renal proximal tubules. Nakamura M; Tsukada H; Seki G; Satoh N; Mizuno T; Fujii W; Horita S; Moriya K; Sato Y; Kume H; Nangaku M; Suzuki M Kidney Int; 2020 Feb; 97(2):316-326. PubMed ID: 31735358 [TBL] [Abstract][Full Text] [Related]
3. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). García-Martínez JM; Alessi DR Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875 [TBL] [Abstract][Full Text] [Related]
4. mTOR signaling in renal ion transport. Adella A; de Baaij JHF Acta Physiol (Oxf); 2023 May; 238(1):e13960. PubMed ID: 36906912 [TBL] [Abstract][Full Text] [Related]
5. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism. Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304 [TBL] [Abstract][Full Text] [Related]
6. The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase. Mori S; Nada S; Kimura H; Tajima S; Takahashi Y; Kitamura A; Oneyama C; Okada M PLoS One; 2014; 9(2):e88891. PubMed ID: 24558442 [TBL] [Abstract][Full Text] [Related]
7. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. Feldman ME; Apsel B; Uotila A; Loewith R; Knight ZA; Ruggero D; Shokat KM PLoS Biol; 2009 Feb; 7(2):e38. PubMed ID: 19209957 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct. Brown AL; Fluitt MB; Ecelbarger CM Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113 [TBL] [Abstract][Full Text] [Related]
9. Growing knowledge of the mTOR signaling network. Huang K; Fingar DC Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279 [TBL] [Abstract][Full Text] [Related]
10. TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression. Das F; Bera A; Ghosh-Choudhury N; Abboud HE; Kasinath BS; Choudhury GG PLoS One; 2014; 9(10):e109608. PubMed ID: 25333702 [TBL] [Abstract][Full Text] [Related]
11. Coordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium. Demko J; Saha B; Takagi E; Mannis A; Weber R; Pearce D bioRxiv; 2024 Jun; ():. PubMed ID: 38979219 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Lamming DW; Ye L; Katajisto P; Goncalves MD; Saitoh M; Stevens DM; Davis JG; Salmon AB; Richardson A; Ahima RS; Guertin DA; Sabatini DM; Baur JA Science; 2012 Mar; 335(6076):1638-43. PubMed ID: 22461615 [TBL] [Abstract][Full Text] [Related]
13. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma. Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736 [TBL] [Abstract][Full Text] [Related]
14. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction. Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905 [TBL] [Abstract][Full Text] [Related]
15. Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives. Ong PS; Wang LZ; Dai X; Tseng SH; Loo SJ; Sethi G Front Pharmacol; 2016; 7():395. PubMed ID: 27826244 [TBL] [Abstract][Full Text] [Related]